PR Newswire

The newsfeed available here is provided by our content partner PR Newswire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 59
6.405,11 S&P · 16,78 Vola-Index · 118.384,91 BTC · 1,16419 EURUSD
System-State: Number of processed items 116.697 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
PR Newswire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
State: 10.08.2025 | 11AM
Tue, 29.04.2025       Nagarro
DE000A3H2200

Umsatz in Höhe von 972,0 Mio. €Gross Margin in Höhe von 30,4 %Bereinigte EBITDA-Marge in Höhe von 15,1 %

MÜNCHEN, 29. April 2025 /PRNewswire/ -- Nagarro, ein weltweit führendes Unternehmen für Digital Engineering, hat heute seine vorläufigen, ungeprüften Finanzzahlen für das am 31. Dezember 2024 endende Geschäftsjahr bekannt gegeben. Der Umsatz stieg im Jahr 2024 auf 972,0 Mio. €, gegenüber 912,1 Mio. € im Jahr 2023, was einem Wachstum von 6,6 % gegenüber dem Vorjahr entspricht. Der währungsbereinigte Umsatzanstieg betrug 7,2 %. Nagarro hat die Definition der Umsatzkosten ab dem ersten Quartal 2024 überarbeitet, um sie besser an die anderer IT-Dienstleistungsunternehmen anzupassen. Der Gross Profit stieg 2024 gemäß der aktuellen Methode auf 295,8 Mio. € (entsprechend einer Gross Margin von 30,4 %) und gemäß der vorherigen Methode auf 253,9 Mio. € (entsprechend einer Gross Margin von 26,1 %), gegenüber 235,7 Mio. € im Jahr 2023 gemäß der vorherigen Methode (entsprechend einer Gross Margin von 25,8 %). Das bereinigte EBITDA stieg von 126,1 Mio. € im Jahr 2023 auf 146,5 Mio. € im Jahr 2024. Die bereinigte EBITDA-Marge stieg 2024 auf 15,1 % gegenüber 13,8 % im Jahr 2023.

Read More
Nagarro
Technical Analysis Termsheet Terminal
Permalink
Freedom Holding
Freedom Holding Corp. reports 17% revenue growth in Q1 FY2026 driven by strong insurance and banking segments
© PR Newswire
Flywire
FLYW Investors Have Opportunity to Lead Flywire Corporation Securities Fraud Lawsuit
© PR Newswire
Replimune Group
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm
© PR Newswire
Thumzup Media
Thumzup Media Corporation Announces Update to the Terms of its Proposed Public Offering
© PR Newswire
3D Systems
DDD Investors with Losses in Excess of $100K Have Opportunity to Lead 3D Systems Corporation Securities Fraud Lawsuit
© PR Newswire
Lockheed Martin
LMT Investors Have Opportunity to Lead Lockheed Martin Corporation Securities Fraud Lawsuit
© PR Newswire
Luminar Technologies
LAZR Investors Have Opportunity to Lead Luminar Technologies, Inc. Securities Fraud Lawsuit
© PR Newswire
RxSight
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
© PR Newswire
Altimmune
ALT Investors Have the Opportunity to Lead the Altimmune Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
© PR Newswire
RxSight
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST
© PR Newswire
Sable Offshore
Faruqi & Faruqi Reminds Sable Offshore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 26, 2025 - SOC
© PR Newswire
Rocket Pharmaceuticals
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT
© PR Newswire
Replimune Group
Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
© PR Newswire
PepGen
Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPG
© PR Newswire
Petco Health and Wellness
Faruqi & Faruqi Reminds Petco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 29, 2025 - WOOF
© PR Newswire
Robosense Technology Co., Ltd
RoboSense Showcases Active Camera at WRC 2025, Defining the "The Real Eye of Robots"
© PR Newswire
Sable Offshore
SABLE OFFSHORE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Sable Offshore Corp. - SOC
© PR Newswire
Neogen
NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
© PR Newswire
Hims & Hers Health
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
© PR Newswire
Sarepta Therapeutics
SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
© PR Newswire
Sable Offshore
SOC Investors Have Opportunity to Lead Sable Offshore Corp. Securities Lawsuit Filed by The Rosen Law Firm
© PR Newswire
Capricor Therapeutics
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
© PR Newswire
Altimmune
Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
© PR Newswire
Thumzup Media
Thumzup Media Corporation Announces Proposed Public Offering
© PR Newswire
Crown Capital Partners Inc.
Crown Capital Partners Announces Q2 2025 Financial Results
© PR Newswire

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.